Expensive, newer stents not better for all patients
NEW YORK (Reuters Health) – Many heart patients get newer, pricey stents inserted during artery-clearing procedures, even if it’s not clear they’d be worse off with more basic models, a new study suggests. Along with being more costly, so-called drug-eluting stents require patients to take aspirin and other blood-thinning drugs for a longer period of time after their procedure – which may mean they have to put off future elective surgeries because of bleeding risks, according to one researcher who worked on the report. …